Caroline Caperton, MD, MSPH

05/08/2026

Such an outstanding showcase of research by our WK residents and their mentors! ❤️🤓

04/24/2026

While broadly following AAFP and AAP guidelines, the foundation supports IDSA’s new recommendation that all immunocompromised adults ages 18+ receive a respiratory syncytial virus (RSV) vaccine.

04/24/2026

Peer support member Caroline has a message for anyone still on the fence about reaching out.

“It’s okay to take the next step at your own pace and start small—but don’t underestimate how meaningful support programs can be. Connecting with others who truly understand life with immune deficiency can be incredibly validating.”

April is PI Awareness Month, and today is the first day of World PI Week. There’s no better time to find your community. Get support here: https://bit.ly/4sqIUM2

04/24/2026

I had so much fun making this podcast on with Darrell Rebouche for Willis Knighton Health. Here is the YouTube link to the full episode. You can also find out wherever you listen to your podcasts. Do check out my colleagues’ episodes also (Dr. Meghan Harris, Dr. Lavo, Dr. Noles,Dr. Rosen, & Dr. Bocchini). & More to come… Always learning to continuously improve the health & well-being of the people we serve. 🩺❤️🫶🏻

https://youtu.be/vLzB8wq_JnU?si=REvOcV_fgV2Y8poW

Apple Podcasts: https://podcasts.apple.com/us/podcast/health-on-point/id1884063107?i=1000754908775

iHeart Radio: https://www.iheart.com/podcast/269-health-on-point-326266062/episode/peanuts-panic-and-data-326589726?app=listen

Spotify: https://open.spotify.com/episode/6sq7gV8ejEygxZBWKkqyyd?si=Eksus6fGQ9W8gQuVmIwIwQ

Pandora: https://www.pandora.com/podcast/health-on-point/peanuts-panic-and-data/PE:1322613037

04/08/2026

Anaphylaxis in infants and toddlers can look a little different than in older children and adults. Learn more about the signs and symptoms at: https://kidswithfoodallergies.org/research/our-food-allergy-research/food-allergy-anaphylaxis-in-infants/

04/08/2026

The FDA has removed the age restriction for neffy 1 mg, expanding access to a needle-free epinephrine option for children at risk of severe allergic reactions.

Eligibility is now based on weight alone, meaning patients who weigh at least 33 lbs (15 kg) can use neffy 1 mg regardless of age. This change is especially important for younger children who previously met the weight requirement but were excluded due to age limits.

For FARE, this matters because increasing epinephrine options help overcome real-world treatment barriers. More choices allow families to select what works best for them and empower families to act confidently when treating anaphylaxis.

03/20/2026

02/04/2026

Pensacola doctors are reporting the first measles case in Escambia County in 20 years. See link below ⬇️ bit.ly/4c5RVp5

02/04/2026

South Carolina measles outbreak hits 876 with 29 new cases

Among confirmed cases, 800 case-patients are unvaccinated against measles.

https://www.cidrap.umn.edu/south-carolina-measles-outbreak-hits-876-29-new-cases

02/04/2026

The FDA has issued a Complete Response Letter for Anaphylm™, a dissolvable orally delivered epinephrine film developed by Aquestive Therapeutics, citing concerns related to usability rather than effectiveness.
Importantly, the FDA did not request new studies on Anaphylm’s efficacy or overall safety. Instead, it is requiring additional human-factors and usability validation studies.
Aquestive plans to complete these studies and resubmit its application in Q3 2026, requesting a rapid review.
Epinephrine remains the first-line treatment for anaphylaxis. Regulatory decisions like this underscore the importance of not only developing effective treatments but also ensuring they can be used quickly, correctly, and confidently when seconds matter.
FARE supports continued innovation and remains hopeful as the FDA and Aquestive Therapeutics work through the next steps for the benefit of the food allergy community.

02/01/2026

The AAP’s recommended pacing of childhood vaccines considers when children are most likely to be exposed to contagious diseases and when children’s immune systems will respond best. This timing has kept millions of kids healthy, so they can focus on growing, playing, and learning.

Our recommendations are based on decades of research and the expertise of pediatricians and public health professionals. Learn more about AAP's 2026 immunization schedule: https://bit.ly/2TPNAkc